Stoke Therapeutics, Inc.

NASDAQ:STOK

20.68 (USD) • At close September 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 13.817158.56922.6144.8944.8314.2162.8023.308-2.4815.1523.2692.9053.23130000000000000000
Kosten van de omzet 01.0761.1081.1111.111.1131.2151.21.1671.1471.1520.9240.8350.6240.6210.5760.5260.507000000000000
Brutowinst 13.817158.56922.6144.8943.7213.1031.5872.108-3.6484.0052.1171.9812.3962.376-0.621-0.576-0.526-0.507000000000000
Brutowinstmarge 11110.770.7360.5660.6371.470.7770.6480.6820.7420.7920000000000000000
Onderzoek- en ontwikkelingskosten 25.85532.67623.42322.20520.58821.80521.15420.27120.55119.63121.06120.10918.35818.30915.80214.35814.0959.9138.9048.1097.9687.2157.0896.5186.0234.1333.0042.2271.8881.252
Algemene en administratieve kosten 15.26214.65312.84412.69213.03710.2210.6110.27110.2310.2119.3839.94410.1119.4868.7248.3257.9346.9145.6825.6025.0444.523.9793.3242.4222.1891.5381.091.1220.66
Verkoop- en marketingkosten 0000-0.562-0.55-0.59100000000000000000000000
Verkoop-, algemene en administratieve kosten 15.26214.65312.84412.69212.4759.6710.01910.27110.2310.2119.3839.94410.1119.4868.7248.3257.9346.9145.6825.6025.0444.523.9793.3242.4222.1891.5381.091.1220.66
Overige kosten 000000000.0410.0420.0410.0420.0420.0420.0420.0420.0280.0160.0150.0160.0030.0220.0040.002-0.00300000
Bedrijfskosten 41.11747.32936.26734.89733.06331.47531.17330.54230.78129.84230.44430.05328.46927.79524.52622.68322.02916.82714.58613.71113.01211.73511.0689.8428.4456.3224.5423.3173.011.912
Bedrijfsresultaat -27.3111.24-13.653-30.003-29.342-28.372-29.586-27.234-33.262-20.442-27.175-27.148-25.238-24.795-24.526-22.683-22.029-16.827-14.586-13.711-13.012-11.735-11.068-9.842-8.445-6.322-4.542-3.317-3.01-1.912
Bedrijfsresultaat ratio -1.9760.702-0.604-6.131-6.074-6.73-10.559-8.23313.407-3.968-8.313-9.345-7.811-8.2650000000000000000
Totaal overige inkomsten en kosten netto 3.8172.9173.1713.5733.6471.9982.6282.6922.6082.1451.521.0370.5860.1460.0780.0860.0620.0340.0250.0270.0530.6960.9081.2380.6260.580.26000
Inkomen voor belasting -23.483114.157-10.482-26.43-25.695-26.374-26.958-24.542-30.654-22.545-25.655-26.111-24.652-24.649-24.448-22.597-21.967-16.793-14.561-13.684-12.959-11.039-10.16-8.604-7.819-5.742-4.282-3.317-3.01-1.912
Inkomen voor belasting ratio -1.70.72-0.464-5.4-5.319-6.256-9.621-7.41912.356-4.376-7.848-8.988-7.63-8.2160000000000000000
Belastingkosten 01.2780000000-4.248-3.608-2.032-1.432-0.25-0.078-0.044-0.0340-0.010-0.05000000000
Nettowinst -23.483112.879-10.482-26.43-25.695-26.374-26.958-24.542-30.654-18.297-22.047-24.079-23.22-24.399-24.448-22.597-21.967-16.793-14.561-13.684-12.959-11.039-10.16-8.604-7.819-5.742-4.282-3.317-3.01-1.912
Nettowinstmarge -1.70.712-0.464-5.4-5.319-6.256-9.621-7.41912.356-3.551-6.744-8.289-7.187-8.1330000000000000000
WPA (Winst Per Aandeel) -0.41.95-0.18-0.47-0.46-0.57-0.6-0.55-0.69-0.43-0.56-0.61-0.59-0.65-0.66-0.61-0.6-0.46-0.44-0.41-0.39-0.34-0.31-0.26-0.25-0.19-0.18-0.14-0.13-0.081
Verwaterde WPA -0.41.9-0.18-0.47-0.46-0.57-0.6-0.55-0.69-0.43-0.56-0.61-0.59-0.65-0.66-0.61-0.6-0.46-0.44-0.41-0.39-0.34-0.31-0.26-0.25-0.19-0.18-0.14-0.13-0.081
EBITDA -26.854111.717-13.127-29.463-28.794-27.809-28.962-26.597-32.651-24.093-26.567-26.76-24.936-24.548-24.291-22.429-21.78-16.591-14.349-13.477-12.788-11.542-10.929-9.716-8.34-6.242-4.467-3.253-2.967-1.88
EBITDA ratio -1.9440.705-0.58-6.02-5.96-6.596-10.336-8.0413.16-4.676-8.127-9.212-7.718-8.1830000000000000000